Dr. Gilbert is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1660 Springhill Ave.
Mobile, AL 36604Phone+1 251-410-1010Fax+1 251-445-8363
Summary
- Dr. Robert A. Gilbert is a Radiation Oncologist, delivering cutting-edge technology and treatment for cancer patients. He completed a Research Fellowship at Baylor College of Medicine in Houston, TX. He is an Assistant Professor of Interdisciplinary Clinical Oncology at the USA College of Medicine.
Education & Training
- Baylor College of MedicineResidency, Radiation Oncology, 1991 - 1994
- Baylor College of MedicineInternship, Internal Medicine, 1990 - 1991
- Baylor College of MedicineClass of 1990
Certifications & Licensure
- AL State Medical License 1995 - 2024
- TX State Medical License 1991 - 2024
- GA State Medical License 2012 - 2020
- FL State Medical License 1996 - 2016
- OK State Medical License 2013 - 2016
- American Board of Radiology Radiation Oncology
Clinical Trials
- Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy Start of enrollment: 2005 Sep 01
- Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2008 Jun 01
- Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsThe adherence to the American Association for the Study of Liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survival.Ashish Manne, Madhuri Mulekar, Daisy Escobar, Pranitha Prodduturvar, Yazan Fahmawi
Journal of Cancer Research and Therapeutics. 2023-10-03 - 5 citationsClinical and Hematological Predictors of High-Grade Immune-Related Adverse Events Associated With Immune Checkpoint InhibitorsAshish Manne, Madhuri S. Mulekar, Daisy E Escobar, Alhareth Alsayed, Gaurav Sharma
Journal of Clinical Medicine Research. 2021-05-25
Press Mentions
- Mitchell Cancer Institute Launches New Radiation Technology for PatientsMay 10th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: